CNIO participates in a study identifying a novel oncogene for most common types of blood cancer

The study shows that tumour suppressor hnRNP K can lead to cancer. Overexpression of the gene may lead to B-cell lymphoma, the most common type of blood cancer. Lymphoma patients might benefit from more personalised treatments.
Source: EurekaAlert, https://www.eurekalert.org